Advanz Gains Temporary Block On Ocaliva’s Removal From EU Market

 
• By Andrew McConaghie
  
Primary Bilary Cholangitis
Ocaliva is for the treatment of the rare liver disease primary biliary cholangitis • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet